Cholinergic dysfunction with significant increase in the vesicular acetylcholine transporter, used to assess cholinergic function in Alzheimer’s disease and Parkinson, has been described in the dorsal striatum of the Tor1a+/−mouse model of DYT1 dystonia. This evidence concerns the gene SLC18A3 and early-onset autosomal dominant Alzheimer disease.